Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Mar 6;82(7):1271–1275. doi: 10.1054/bjoc.1999.1090

The expression of MDM2/CDK4 gene product in the differential diagnosis of well differentiated liposarcoma and large deep-seated lipoma

S Pilotti 1, G Della Torre 2, A Mezzelani 1, E Tamborini 1, A Azzarelli 3, G Sozzi 2, M A Pierotti 2
PMCID: PMC2374492  PMID: 10755400

Abstract

Ordinary lipomas are cytogenetically characterized by a variety of balanced rearrangements involving chromosome segment 12q13–15, whereas well differentiated liposarcomas (WDL) show supernumerary ring and giant marker chromosomes, known to contain amplified 12q sequences. The tight correlation between the presence of ring chromosomes and both amplification and overexpression of MDM2 and CDK4 genes suggests the exploration of the possibility that immunocytochemistry (ICC) might assist in the differential diagnosis of lipoma-like well differentiated liposarcomas (LL-WDL) and large deep-seated lipomas (LDSL). For this purpose, 21 cases of the former and 19 cases of the latter tumours were analysed by ICC and, according to the availability of material, by molecular and cytogenetic approaches. All lipomas displayed a null MDM2/CDK4 phenotype, whereas all LL-WDL showed MDM2/CDK4 or CDK4 phenotypes. Southern blot analysis performed on 16 suitable cases, complemented by fluorescence in situ hybridization and classical cytogenetic analysis in 11 cases, was consistent with, and further supported the immunophenotyping data. In conclusion, MDM2/CDK4 product-based immunophenotyping appears to represent a valuable method for the categorization of arguable LDSL. © 2000 Cancer Research Campaign

Keywords: MDM2, CDK4, lipoma, liposarcoma lipoma-like, differential diagnosis

Full Text

The Full Text of this article is available as a PDF (118.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berner J. M., Meza-Zepeda L. A., Kools P. F., Forus A., Schoenmakers E. F., Van de Ven W. J., Fodstad O., Myklebost O. HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas. Oncogene. 1997 Jun 19;14(24):2935–2941. doi: 10.1038/sj.onc.1201135. [DOI] [PubMed] [Google Scholar]
  2. DEWEERD J. H., DOCKERTY M. B. Lipomatous retroperitoneal tumors. Am J Surg. 1952 Oct;84(4):397–407. doi: 10.1016/0002-9610(52)90004-4. [DOI] [PubMed] [Google Scholar]
  3. Dal Cin P., Kools P., Sciot R., De Wever I., Van Damme B., Van de Ven W., Van den Berghe H. Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. Cancer Genet Cytogenet. 1993 Jul 15;68(2):85–90. doi: 10.1016/0165-4608(93)90001-3. [DOI] [PubMed] [Google Scholar]
  4. Dei Tos A. P., Dal Cin P. The role of cytogenetics in the classification of soft tissue tumours. Virchows Arch. 1997 Aug;431(2):83–94. doi: 10.1007/s004280050073. [DOI] [PubMed] [Google Scholar]
  5. Fletcher C. D., Akerman M., Dal Cin P., de Wever I., Mandahl N., Mertens F., Mitelman F., Rosai J., Rydholm A., Sciot R. Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am J Pathol. 1996 Feb;148(2):623–630. [PMC free article] [PubMed] [Google Scholar]
  6. Forus A., Flørenes V. A., Maelandsmo G. M., Meltzer P. S., Fodstad O., Myklebost O. Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2. Cell Growth Differ. 1993 Dec;4(12):1065–1070. [PubMed] [Google Scholar]
  7. Hunter T., Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell. 1994 Nov 18;79(4):573–582. doi: 10.1016/0092-8674(94)90543-6. [DOI] [PubMed] [Google Scholar]
  8. Khatib Z. A., Matsushime H., Valentine M., Shapiro D. N., Sherr C. J., Look A. T. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res. 1993 Nov 15;53(22):5535–5541. [PubMed] [Google Scholar]
  9. Leach F. S., Tokino T., Meltzer P., Burrell M., Oliner J. D., Smith S., Hill D. E., Sidransky D., Kinzler K. W., Vogelstein B. p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res. 1993 May 15;53(10 Suppl):2231–2234. [PubMed] [Google Scholar]
  10. Lichter P., Tang C. J., Call K., Hermanson G., Evans G. A., Housman D., Ward D. C. High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science. 1990 Jan 5;247(4938):64–69. doi: 10.1126/science.2294592. [DOI] [PubMed] [Google Scholar]
  11. Mandahl N., Akerman M., Aman P., Dal Cin P., De Wever I., Fletcher C. D., Mertens F., Mitelman F., Rosai J., Rydholm A. Duplication of chromosome segment 12q15-24 is associated with atypical lipomatous tumors: a report of the CHAMP collaborative study group. CHromosomes And MorPhology. Int J Cancer. 1996 Sep 4;67(5):632–635. doi: 10.1002/(SICI)1097-0215(19960904)67:5<632::AID-IJC7>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
  12. Mentzel T., Fletcher C. D. Lipomatous tumours of soft tissues: an update. Virchows Arch. 1995;427(4):353–363. doi: 10.1007/BF00199383. [DOI] [PubMed] [Google Scholar]
  13. Mezzelani A., Sozzi G., Pierotti M. A., Pilotti S. Rapid differential diagnosis of myxoid liposarcoma by fluorescence in situ hybridisation on cytological preparations. Clin Mol Pathol. 1996 Oct;49(5):M308–M309. doi: 10.1136/mp.49.5.m308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nilbert M., Rydholm A., Willén H., Mitelman F., Mandahl N. MDM2 gene amplification correlates with ring chromosome in soft tissue tumors. Genes Chromosomes Cancer. 1994 Apr;9(4):261–265. doi: 10.1002/gcc.2870090406. [DOI] [PubMed] [Google Scholar]
  15. Pedeutour F., Suijkerbuijk R. F., Van Gaal J., Van de Klundert W., Coindre J. M., Van Haelst A., Collin F., Huffermann K., Turc-Carel C. Chromosome 12 origin in rings and giant markers in well-differentiated liposarcoma. Cancer Genet Cytogenet. 1993 Apr;66(2):133–134. doi: 10.1016/0165-4608(93)90245-h. [DOI] [PubMed] [Google Scholar]
  16. Petit M. M., Mols R., Schoenmakers E. F., Mandahl N., Van de Ven W. J. LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family. Genomics. 1996 Aug 15;36(1):118–129. doi: 10.1006/geno.1996.0432. [DOI] [PubMed] [Google Scholar]
  17. Pilotti S., Della Torre G., Lavarino C., Di Palma S., Sozzi G., Minoletti F., Rao S., Pasquini G., Azzarelli A., Rilke F. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms. J Pathol. 1997 Jan;181(1):14–24. doi: 10.1002/(SICI)1096-9896(199701)181:1<14::AID-PATH730>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
  18. Pilotti S., Della Torre G., Lavarino C., Sozzi G., Minoletti F., Vergani B., Azzarelli A., Rilke F., Pierotti M. A. Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22. J Pathol. 1998 Jun;185(2):188–190. doi: 10.1002/(SICI)1096-9896(199806)185:2<188::AID-PATH53>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  19. Rosai J., Akerman M., Dal Cin P., DeWever I., Fletcher C. D., Mandahl N., Mertens F., Mitelman F., Rydholm A., Sciot R. Combined morphologic and karyotypic study of 59 atypical lipomatous tumors. Evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of the CHAMP Study Group). Am J Surg Pathol. 1996 Oct;20(10):1182–1189. doi: 10.1097/00000478-199610000-00002. [DOI] [PubMed] [Google Scholar]
  20. Schoenmakers E. F., Wanschura S., Mols R., Bullerdiek J., Van den Berghe H., Van de Ven W. J. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet. 1995 Aug;10(4):436–444. doi: 10.1038/ng0895-436. [DOI] [PubMed] [Google Scholar]
  21. Smith S. H., Weiss S. W., Jankowski S. A., Coccia M. A., Meltzer P. S. SAS amplification in soft tissue sarcomas. Cancer Res. 1992 Jul 1;52(13):3746–3749. [PubMed] [Google Scholar]
  22. Suijkerbuijk R. F., Olde Weghuis D. E., Van den Berg M., Pedeutour F., Forus A., Myklebost O., Glier C., Turc-Carel C., Geurts van Kessel A. Comparative genomic hybridization as a tool to define two distinct chromosome 12-derived amplification units in well-differentiated liposarcomas. Genes Chromosomes Cancer. 1994 Apr;9(4):292–295. doi: 10.1002/gcc.2870090410. [DOI] [PubMed] [Google Scholar]
  23. Szymanska J., Virolainen M., Tarkkanen M., Wiklund T., Asko-Seljavaara S., Tukiainen E., Elomaa I., Blomqvist C., Knuutila S. Overrepresentation of 1q21-23 and 12q13-21 in lipoma-like liposarcomas but not in benign lipomas: a comparative genomic hybridization study. Cancer Genet Cytogenet. 1997 Nov;99(1):14–18. doi: 10.1016/s0165-4608(96)00436-0. [DOI] [PubMed] [Google Scholar]
  24. Tkachenko A., Ashar H. R., Meloni A. M., Sandberg A. A., Chada K. K. Misexpression of disrupted HMGI architectural factors activates alternative pathways of tumorigenesis. Cancer Res. 1997 Jun 1;57(11):2276–2280. [PubMed] [Google Scholar]
  25. Willén H., Akerman M., Dal Cin P., De Wever I., Fletcher C. D., Mandahl N., Mertens F., Mitelman F., Rosai J., Rydholm A. Comparison of chromosomal patterns with clinical features in 165 lipomas: a report of the CHAMP study group. Cancer Genet Cytogenet. 1998 Apr 1;102(1):46–49. doi: 10.1016/s0165-4608(97)00292-6. [DOI] [PubMed] [Google Scholar]
  26. Zauberman A., Flusberg D., Haupt Y., Barak Y., Oren M. A functional p53-responsive intronic promoter is contained within the human mdm2 gene. Nucleic Acids Res. 1995 Jul 25;23(14):2584–2592. doi: 10.1093/nar/23.14.2584. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES